Crohn’s and colitis are much more manageable when we share our experiences with each other. Education events, chapter meetings, and fundraising activities are great opportunities to meet people who are living with IBD, their families and friends, and to learn of local resources and health professionals to support you and your family.

Regional Director, Western Canada
Rubina Sajan
587-225-4194

Leadership Giving Officer, Western Canada
Susan Hampton
604-314-1151

Development Coordinator
Teri McGeachie
250-213-7761
1-800-513-8202

Gutsy Walk Participants

25th Anniversary Gutsy Walk and COVID-19, Registration Now Open

Join us for the 25th anniversary of Gutsy Walk. While the COVID-19 pandemic affects us today – the urgent research you help us fund is long-lasting. With your commitment, we will bring Gutsy ...

 • 
With over 60 virtual walk sites throughout the country. Check for the location nearest to you on our Gutsy Walk Website in the full details Join thousands across Canada on Sunday August 23rd. Walk with us virtually. Anywhere. Anyhow!
 • 
COVID-19 Coronavirus

COVID-19 Updates: Washroom Access During a Pandemic

Thursday, June 4th 20207:00-8:00 pm ET Join us to get the latest recommendations for people affected by IBD. Panel experts will discuss advocacy, safety, and challenges accessing public ...

 • 
Webinar (Online)
 • 
Remember to bookmark this page.

British Columbia & Yukon Office

PO Box 47147 City Square
Vancouver, BC V5Z 4L6

bc@crohnsandcolitis.ca 1-800-513-8202

Search by Postal Code

News

“You don’t need to be superhuman”: How a small-town hockey player made it to the NCAA in the face of Crohn’s disease

“You don’t need to be superhuman”: How a small-town hockey player made it to the NCAA in the face of Crohn’s disease

Takeda Canada announces positive results for ENTYVIO® (vedolizumab) vs. Humira® (adalimumab) in first IBD study to compare biological agents head-to-head

Takeda Canada announces positive results for ENTYVIO® (vedolizumab) vs. Humira® (adalimumab) in first IBD study to compare biological agents head-to-head

 9 10 11 12 13 14 15 16 17 18